Table 2

Demographics table for BAL and EBUS-TBNA samples

BAL samplesEBUS-TBNA samples
Total number of case282139
Age (median with IQR)55 (41–67)53 (41–65)
Clinical category1: culture-confirmed TB21 (7.4%)17 (12.2%)
2: highly probable TB11 (3.9%)9 (6.5%)
3: indeterminate8 (2.8%)14 (10.1%)
4: highly unlikely TB242 (85.8%)99 (71.2%)
GenderMale169 (60%)84 (60%)
Female113 (40%)55 (40%)
Risk factorsPrevious TB23 (8%)8 (6%)
HIV20 (7%)3 (2%)
Diabetes42 (15%)22 (16%)
Chronic kidney disease43 (15%)12 (9%)
Immunosuppressive drugs94 (33%)26 (19%)
IGRAPositive37 (13%)35 (25%)
Negative101 (36%)51 (37%)
Indeterminate9 (3%)4 (3%)
Unknown135 (48%)49 (35%)
EthnicityAsian—other15 (5%)7 (5%)
Asian—Indian subcontinent25 (9%)22 (16%)
Black34 (12%)20 (14%)
Mixed4 (1%)4 (3%)
Other108 (38%)35 (25%)
Unknown1 (<1%)3 (2%)
White95 (34%)48 (35%)
  • BAL, bronchoalveolar lavage; EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration; IGRA, interferon gamma release assay; TB, tuberculosis.